Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer

PURPOSE: Our previous studies suggested that p53-positive triple-negative breast cancer (TNBC) should be more sensitive to chemotherapy than p53-negative TNBC. The aim of this study was to determine whether p53 expression in TNBC could predict response to neoadjuvant chemotherapy and the resulting p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Soo Youn, Lee, Jeong Hyeon, Bae, Jeoung Won, Jung, Seung Pil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263888/
https://www.ncbi.nlm.nih.gov/pubmed/32528908
http://dx.doi.org/10.4174/astr.2020.98.6.291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263888/
https://www.ncbi.nlm.nih.gov/pubmed/32528908
http://dx.doi.org/10.4174/astr.2020.98.6.291

Ejemplares similares